PA
Prism Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-10,345
| Closed | -$100K | – | 55 |
|
|
2020
Q4 | $100K | Hold |
10,345
| – | – | 0.04% | 52 |
|
|
2020
Q3 | $93K | Hold |
10,345
| – | – | 0.04% | 46 |
|
|
2020
Q2 | $128K | Sell |
10,345
-300,008
| -97% | -$3.71M | 0.06% | 45 |
|
|
2020
Q1 | $2.79M | Buy |
310,353
+7,396
| +2% | +$66.4K | 1.8% | 15 |
|
|
2019
Q4 | $2.97M | Buy |
302,957
+28,583
| +10% | +$280K | 1.5% | 14 |
|
|
2019
Q3 | $1.89M | Buy |
274,374
+83,822
| +44% | +$577K | 1.06% | 29 |
|
|
2019
Q2 | $1.76M | Buy |
190,552
+60,372
| +46% | +$557K | 1% | 29 |
|
|
2019
Q1 | $2.04M | Buy |
130,180
+15,072
| +13% | +$236K | 1.17% | 26 |
|
|
2018
Q4 | $1.78M | Sell |
115,108
-2,291
| -2% | -$35.3K | 1.13% | 25 |
|
|
2018
Q3 | $2.49M | Sell |
117,399
-14,752
| -11% | -$313K | 1.45% | 19 |
|
|
2018
Q2 | $3.19M | Sell |
132,151
-5,564
| -4% | -$134K | 1.7% | 11 |
|
|
2018
Q1 | $2.65M | Sell |
137,715
-38,796
| -22% | -$747K | 1.49% | 11 |
|
|
2017
Q4 | $3.35M | Buy |
+176,511
| New | +$3.35M | 1.84% | 7 |
|